ROBINS HARLAN S 4
4 · Adaptive Biotechnologies Corp · Filed Mar 26, 2025
Insider Transaction Report
Form 4
ROBINS HARLAN S
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-24$6.32/sh+1,698$10,731→ 1,281,222 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-24−1,698→ 68,412 totalExercise: $6.32Exp: 2025-06-09→ Common Stock (1,698 underlying) - Sale
Common Stock
2025-03-24$9.00/sh−1,698$15,282→ 1,279,524 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $9.00 to 9.01, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The option is fully vested and exercisable.